Annual report
Page 1
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington , D.C. 20549 Form 10 - K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from Commission File Number : 001-37477 Delaware ( State of incorporation ) 2 Manhattanville Road , Suite 203 Purchase , New York ( Address of principal executive office ) For the year ended December 31 , 2020 Title of each class Common Stock , par value $ 0.001 per share 8i or TELADOC HEALTH , INC . ( Exact name of registrant as specified in its charter ) Large accelerated filer Emerging growth company ■ ( 203 ) 635-2002 ( Registrant's telephone number including area code ) Securities registered pursuant to Section 12 ( b ) of the Act : Trading Symbol ( s ) TDOC to ( I.R.S. Employer Identification No. ) Non - accelerated filer 04-3705970 Securities registered pursuant to Section 12 ( g ) of the Act : Not Applicable Indicate by check mark if the registrant is a well - known seasoned issuer , as defined in Rule 405 of the Securities Act . Yes No Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15 ( d ) of the Exchange Act . Yes No Indicate by check mark whether the registrant : ( 1 ) has filed all reports required to be filed by Section 13 or 15 ( d ) of the Securities Exchange Act of 1934 during the preceding 12 months ( or for such shorter period that the registrant was required to file such reports ) , and ( 2 ) has been subject to such filing requirements for the past 90 days . Yes No Name of each exchange on which registered The New York Stock Exchange Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S - T during the preceding 12 months ( or for such shorter period that the registrant was required to submit and post such files ) . Yes No 10577 ( Zip code ) Indicate by check mark whether the registrant is a large accelerated filer , an accelerated filer , a non - accelerated filer , a smaller reporting company or an emerging growth company . See the definitions of " large accelerated filer , " " accelerated filer , " " smaller reporting company , " and " emerging growth company " in Rule 12b - 2 of the Exchange Act . ( Check one ) : Accelerated filer ☐ DOCUMENTS INCORPORATED BY REFERENCE Smaller reporting company If an emerging growth company , indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13 ( a ) of the Exchange Act . Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404 ( b ) of the Sarbanes - Oxley Act ( 15 U.S.C. 7262 ( b ) ) by the registered public accounting firm that prepared or issued its audit report . Indicate by check mark whether the registrant is a shell company ( as defined in Rule 12b - 2 of the Exchange Act . ) Yes No The aggregate market value of the common stock held by non - affiliates as of the last business day of the registrant's most recently completed second fiscal quarter was approximately $ 14,936,555,578 . The registrant has no non - voting stock outstanding . As of February 25 , 2021 , there were 152,699,999 shares of common stock outstanding . Portions of the registrant's definitive proxy statement to be delivered to stockholders in connection with the 2021 annual meeting of stockholders are incorporated by reference in response to Part III of this Report to the extent stated herein .